JP5977331B2 - 高い嵩密度と良好な流動性を有するセルロース誘導体の製造方法 - Google Patents
高い嵩密度と良好な流動性を有するセルロース誘導体の製造方法 Download PDFInfo
- Publication number
- JP5977331B2 JP5977331B2 JP2014503690A JP2014503690A JP5977331B2 JP 5977331 B2 JP5977331 B2 JP 5977331B2 JP 2014503690 A JP2014503690 A JP 2014503690A JP 2014503690 A JP2014503690 A JP 2014503690A JP 5977331 B2 JP5977331 B2 JP 5977331B2
- Authority
- JP
- Japan
- Prior art keywords
- cellulose derivative
- cellulose
- airflow
- gas
- wet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229920002678 cellulose Polymers 0.000 title claims description 198
- 239000001913 cellulose Substances 0.000 title claims description 196
- 238000004519 manufacturing process Methods 0.000 title description 11
- 238000000034 method Methods 0.000 claims description 62
- 239000007788 liquid Substances 0.000 claims description 39
- 229920003086 cellulose ether Polymers 0.000 claims description 30
- 238000001035 drying Methods 0.000 claims description 29
- 238000004090 dissolution Methods 0.000 claims description 23
- 238000000227 grinding Methods 0.000 claims description 14
- 238000010298 pulverizing process Methods 0.000 claims description 11
- 238000002844 melting Methods 0.000 claims description 6
- 230000008018 melting Effects 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 3
- 235000010980 cellulose Nutrition 0.000 description 174
- 239000007789 gas Substances 0.000 description 47
- 239000002245 particle Substances 0.000 description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 28
- 239000002552 dosage form Substances 0.000 description 23
- 239000004480 active ingredient Substances 0.000 description 21
- -1 hydroxypropyl Chemical group 0.000 description 21
- 230000000052 comparative effect Effects 0.000 description 17
- 238000013268 sustained release Methods 0.000 description 11
- 239000012730 sustained-release form Substances 0.000 description 11
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 10
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 9
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 9
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 8
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 8
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 8
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 8
- 238000010191 image analysis Methods 0.000 description 8
- 239000000546 pharmaceutical excipient Substances 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 7
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 238000006467 substitution reaction Methods 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 229920013820 alkyl cellulose Polymers 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 239000008187 granular material Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 5
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 description 5
- 239000002671 adjuvant Substances 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 238000013270 controlled release Methods 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 230000002209 hydrophobic effect Effects 0.000 description 5
- 229920000609 methyl cellulose Polymers 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 239000001923 methylcellulose Substances 0.000 description 5
- 235000010981 methylcellulose Nutrition 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 4
- 229920000896 Ethulose Polymers 0.000 description 4
- 239000001859 Ethyl hydroxyethyl cellulose Substances 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 229920003091 Methocel™ Polymers 0.000 description 4
- 239000008186 active pharmaceutical agent Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 235000019326 ethyl hydroxyethyl cellulose Nutrition 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- RFRMMZAKBNXNHE-UHFFFAOYSA-N 6-[4,6-dihydroxy-5-(2-hydroxyethoxy)-2-(hydroxymethyl)oxan-3-yl]oxy-2-(hydroxymethyl)-5-(2-hydroxypropoxy)oxane-3,4-diol Chemical compound CC(O)COC1C(O)C(O)C(CO)OC1OC1C(O)C(OCCO)C(O)OC1CO RFRMMZAKBNXNHE-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 3
- 238000007907 direct compression Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000011236 particulate material Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 150000004804 polysaccharides Chemical class 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229920003090 carboxymethyl hydroxyethyl cellulose Polymers 0.000 description 2
- 239000012159 carrier gas Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000003703 image analysis method Methods 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 238000003801 milling Methods 0.000 description 2
- 229940029985 mineral supplement Drugs 0.000 description 2
- 235000020786 mineral supplement Nutrition 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- CWSZBVAUYPTXTG-UHFFFAOYSA-N 5-[6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxy-5-[4-hydroxy-3-(2-hydroxyethoxy)-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol Chemical compound O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)OCCO)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 CWSZBVAUYPTXTG-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000224489 Amoeba Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical group CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920003096 Methocel™ K100M Polymers 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000012867 bioactive agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 150000004648 butanoic acid derivatives Chemical class 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000005056 compaction Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 208000027744 congestion Diseases 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012374 esterification agent Substances 0.000 description 1
- 238000006266 etherification reaction Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000013265 extended release Methods 0.000 description 1
- 235000020650 eye health related herbal supplements Nutrition 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 239000007887 hard shell capsule Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000003345 natural gas Substances 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 235000019195 vitamin supplement Nutrition 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B11/00—Preparation of cellulose ethers
- C08B11/20—Post-etherification treatments of chemical or physical type, e.g. mixed etherification in two steps, including purification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
- B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
- B02C13/00—Disintegrating by mills having rotary beater elements ; Hammer mills
- B02C13/26—Details
- B02C13/288—Ventilating, or influencing air circulation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
- B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
- B02C23/00—Auxiliary methods or auxiliary devices or accessories specially adapted for crushing or disintegrating not provided for in preceding groups or not specially adapted to apparatus covered by a single preceding group
- B02C23/18—Adding fluid, other than for crushing or disintegrating by fluid energy
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
- B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
- B02C23/00—Auxiliary methods or auxiliary devices or accessories specially adapted for crushing or disintegrating not provided for in preceding groups or not specially adapted to apparatus covered by a single preceding group
- B02C23/18—Adding fluid, other than for crushing or disintegrating by fluid energy
- B02C23/24—Passing gas through crushing or disintegrating zone
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B11/00—Preparation of cellulose ethers
- C08B11/193—Mixed ethers, i.e. ethers with two or more different etherifying groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/12—Powdering or granulating
- C08J3/124—Treatment for improving the free-flowing characteristics
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
- C08L1/08—Cellulose derivatives
- C08L1/26—Cellulose ethers
- C08L1/28—Alkyl ethers
- C08L1/284—Alkyl ethers with hydroxylated hydrocarbon radicals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
- B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
- B02C23/00—Auxiliary methods or auxiliary devices or accessories specially adapted for crushing or disintegrating not provided for in preceding groups or not specially adapted to apparatus covered by a single preceding group
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2301/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
- C08J2301/08—Cellulose derivatives
- C08J2301/26—Cellulose ethers
- C08J2301/28—Alkyl ethers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Food Science & Technology (AREA)
- Inorganic Chemistry (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Cosmetics (AREA)
Description
A)湿潤したセルロース誘導体の全重量に対して、60〜95%の含液率を有するセルロース誘導体を提供する工程と、
B)気流式衝撃型粉砕機(gas-swept impact mill)において湿潤したセルロース誘導体を粉砕し、部分乾燥する工程と、
C)前記衝撃型粉砕機の外側において、追加量の乾燥ガスに前記粉砕及び部分乾燥したセルロース誘導体を接触させる工程と、
を含む方法である。
A)湿潤したセルロース誘導体の全重量に対して、60〜95%の含液率を有するセルロース誘導体を提供する工程と、
B)気流式衝撃型粉砕機において湿潤したセルロース誘導体を粉砕し、部分乾燥する工程と、
C)前記衝撃型粉砕機の外側において、追加量の乾燥ガスに前記粉砕及び部分乾燥したセルロース誘導体を接触させる工程と、
を含む方法である。
乾燥したMETHOCELTMK100Mセルロースエーテルに水を添加するために、市販の加熱及び冷却ジャケット付きの連続混合機を使用した。この混合機のジャケットには、−16℃〜73℃の流体を供給した。前記混合機のジャケット内の流体は、乾燥及び粉砕する前に前記セルロースエーテルの温度を調整するために使用したが、前記混合機内の前記セルロースエーテルに混合される水がたったの2〜11℃であったため、前記セルロースエーテルの温度を個々に測定すると、該セルロースエーテルの温度は、前記混合機のジャケット内の流体温度には到底及ばなかった。
22.6%のメトキシル基置換度及び10.3%のヒドロキシプロポキシル基置換度、並びに114,700Pa・sの粘度を有するヒドロキシプロピルメチルセルロースを、比較例の材料として使用した。これは、CRセルロースエーテルと称される、当技術分野における放出制御グレードのセルロースエーテルを代表するものである。この放出制御グレードのセルロースエーテルの製造は、米国特許第4,734,285号明細書に開示されている。
22.7%のメトキシル基置換度、10.0%のヒドロキシプロポキシル基置換度及び103,300mPa・sの粘度を有する、ヒドロキシプロピルメチルセルロースを、比較例の材料として使用した。この比較例Hのヒドロキシプロピルメチルセルロースは、WO2008/127794号などに記載されている造粒法によって製造することができる。比較例Hのヒドロキシプロピルメチルセルロースを、「直接打錠」(DC)セルロースエーテルと呼ぶ。
前記セルロース誘導体の初期溶解温度は、上記でより詳細に説明したように、HAAKE RS 1粘度計を用いて、水中の生成物の粘度上昇を測定することによって決定した。
本開示は以下も包含する。
[1] 湿潤したセルロース誘導体を粉砕及び乾燥することによって粒子状のセルロース誘導体を製造する方法であって、該方法は、
A)湿潤したセルロース誘導体の全重量に対して、60〜95%の含液率を有するセルロース誘導体を提供する工程と、
B)気流式衝撃型粉砕機において、湿潤したセルロース誘導体を粉砕し、部分乾燥する工程と、
C)前記衝撃型粉砕機の外側において、追加量の乾燥ガスに前記粉砕及び部分乾燥したセルロース誘導体を接触させる工程と、
を含む、前記方法。
[2] 粉砕及び乾燥前の工程A)において、前記セルロース誘導体の含液率が、湿潤したセルロース誘導体の全重量に対して、75〜85%である、上記態様1に記載の方法。
[3] 工程B)の気流式衝撃型粉砕機におけるガス流量と、工程C)の追加量の乾燥ガス流量との比が、1:10〜8:1である、上記態様1又は2のいずれかに記載の方法。
[4] 工程B)において、湿潤したセルロース誘導体及びガスが、セルロース誘導体の乾燥重量に基づいて、セルロース誘導体の単位重量当たり52〜67cm 3 /kgの速度で、前記気流式衝撃型粉砕機に供給され、及び/又は、工程C)において、追加量の乾燥ガスを、セルロース誘導体の乾燥重量に基づいて、セルロース誘導体の単位重量当たり25〜150m 3 /kgの量で、前記セルロース誘導体に接触させる、上記態様1〜3のいずれか一項に記載の方法。
[5] 前記セルロース誘導体がセルロースエーテルである、上記態様1〜4のいずれか一項に記載の方法。
[6] 製造される粒子状のセルロース誘導体が、140μm未満のメジアン等価投影円直径(EQPC)を有する、上記態様1〜5のいずれか一項に記載の方法。
[7] 製造される粒子状のセルロース誘導体が、0.40g/cm 3 以上のアンタップ嵩密度を有する、上記態様1〜6のいずれか一項に記載の方法。
[8] 製造される粒子状のセルロース誘導体が、30以下のCarr指数を有する、上記態様1〜7のいずれか一項に記載の方法。
[9] 製造される粒子状のセルロース誘導体が、61.5℃以上の初期溶解温度を有する、上記態様1〜8のいずれか一項に記載の方法。
[10] 粒子状のセルロース誘導体の流動性及び/又は初期溶解温度を増大させる方法であって、該方法は、
A)湿潤したセルロース誘導体の全重量に対して、60〜95%の含液率を有するセルロース誘導体を提供する工程と、
B)気流式衝撃型粉砕機において湿潤したセルロース誘導体を粉砕し、部分乾燥する工程と、
C)前記衝撃型粉砕機の外側において、追加量の乾燥ガスに前記粉砕及び部分乾燥したセルロース誘導体を接触させる工程と、
を含む、前記方法。
[11] 140μm未満のメジアン等価投影円直径(EQPC)、0.40g/cm 3 以上のアンタップ嵩密度及び30以下のCarr指数を有する、粒子状のセルロース誘導体。
[12] 25以下のCarr指数を有する、上記態様11に記載の粒子状のセルロース誘導体。
[13] 60〜350μmのメジアン粒子長を有する、上記態様11又は12に記載の粒子状のセルロース誘導体。
[14] 61.5℃以上の初期溶解温度を有する、上記態様11〜13のいずれか一項に記載の粒子状のセルロース誘導体。
[15] a)1又は複数の上記態様11〜14のいずれか一項に記載の粒子状のセルロース誘導体と、b)1又は複数の有効成分と、c)1又は複数の任意の添加剤とから製造される剤形。
Claims (5)
- 湿潤したセルロース誘導体を粉砕及び乾燥することによって粒子状のセルロース誘導体を製造する方法であって、該方法は、
A)湿潤したセルロース誘導体の全重量に対して、60〜95%の含液率を有するセルロース誘導体を提供する工程と、
B)気流式衝撃型粉砕機において、湿潤したセルロース誘導体を粉砕し、部分乾燥する工程と、
C)前記気流式衝撃型粉砕機の外側において、追加量の乾燥ガスに前記粉砕及び部分乾燥したセルロース誘導体を接触させる工程と、
を含み、前記セルロース誘導体を、前記気流式衝撃型粉砕機の外側における追加量の乾燥ガスとしての第2のガス流に接触させる際に、前記セルロース誘導体は、前記気流式衝撃型粉砕機を出るガス流の全量又は少なくとも一部に分散される、前記方法。 - セルロース誘導体を乾燥させるために使用されるガス流は、スライド弁を介して2つの流れに分割され、そのうちの一方の第1のガス流は、気流式衝撃型粉砕機内に供給され、他方の第2のガス流は、前記セルロース誘導体を前記第2のガス流に接触させる際に、該セルロース誘導体が前記気流式衝撃型粉砕機を出るガス流の全量又は少なくとも一部に分散するように、前記気流式衝撃型粉砕機から出る粉砕及び部分乾燥されたセルロース誘導体に接触する、請求項1に記載の方法。
- 前記セルロース誘導体がセルロースエーテルである、請求項1又は2に記載の方法。
- 製造される粒子状のセルロース誘導体が、1又は複数の次の特性:
140μm未満のメジアン等価投影円直径(EQPC)、0.40g/cm3以上のアンタップ嵩密度、30.0以下のCarr指数、及び61.5℃以上の初期溶解温度を有する、請求項1〜3のいずれか一項に記載の方法。 - 粒子状のセルロース誘導体の流動性及び/又は初期溶解温度を増大させる方法であって、該方法は、
A)湿潤したセルロース誘導体の全重量に対して、60〜95%の含液率を有するセルロース誘導体を提供する工程と、
B)気流式衝撃型粉砕機において湿潤したセルロース誘導体を粉砕し、部分乾燥する工程と、
C)前記気流式衝撃型粉砕機の外側において、追加量の乾燥ガスに前記粉砕及び部分乾燥したセルロース誘導体を接触させる工程と、
を含み、前記セルロース誘導体を、前記気流式衝撃型粉砕機の外側における追加量の乾燥ガスとしての第2のガス流に接触させる際に、前記セルロース誘導体は、前記気流式衝撃型粉砕機を出るガス流の全量又は少なくとも一部に分散される、前記方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161472225P | 2011-04-06 | 2011-04-06 | |
US61/472,225 | 2011-04-06 | ||
PCT/US2012/031111 WO2012138532A2 (en) | 2011-04-06 | 2012-03-29 | Process for producing cellulose derivatives of high bulk density and good flowability |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2014510184A JP2014510184A (ja) | 2014-04-24 |
JP2014510184A5 JP2014510184A5 (ja) | 2014-11-13 |
JP5977331B2 true JP5977331B2 (ja) | 2016-08-24 |
Family
ID=45932555
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014503690A Active JP5977331B2 (ja) | 2011-04-06 | 2012-03-29 | 高い嵩密度と良好な流動性を有するセルロース誘導体の製造方法 |
Country Status (8)
Country | Link |
---|---|
US (2) | US9352330B2 (ja) |
EP (1) | EP2694035A2 (ja) |
JP (1) | JP5977331B2 (ja) |
KR (2) | KR20180132952A (ja) |
CN (2) | CN103459430B (ja) |
BR (1) | BR112013023380B1 (ja) |
MX (1) | MX343509B (ja) |
WO (1) | WO2012138532A2 (ja) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX343509B (es) * | 2011-04-06 | 2016-11-08 | Dow Global Technologies Llc | Proceso para producir derivados de celulosa de alta densidad aparente y buena fluidez. |
JP5731708B2 (ja) * | 2011-04-06 | 2015-06-10 | ダウ グローバル テクノロジーズ エルエルシー | 新規多糖類誘導体及び剤形 |
MX2014009598A (es) * | 2012-02-10 | 2014-11-10 | Dow Global Technologies Llc | Composicion para cuerpos ceramicos moldeados por extrusion que comprende un derivado de celulosa de determinado largo medio de particula. |
US9340624B2 (en) * | 2012-09-25 | 2016-05-17 | Dow Global Technologies Llc | Process for producing cellulose derivatives of high bulk density, good flowability and/or dispersibility in cold water as well as low solution color |
WO2014052217A1 (en) * | 2012-09-27 | 2014-04-03 | Dow Global Technologies Llc | Methods for reducing oil and / or fat uptake of fried foods |
WO2014165241A1 (en) | 2013-03-12 | 2014-10-09 | Hercules Incorporated | Coprocessed silica coated polymer composition |
WO2015041973A1 (en) * | 2013-09-23 | 2015-03-26 | Dow Global Technologies Llc | A process for recovering an esterified cellulose ether from a reaction product mixture |
WO2015163448A1 (ja) | 2014-04-25 | 2015-10-29 | 中外製薬株式会社 | 4環性化合物を高用量含有する製剤 |
EP3303406B1 (en) | 2015-06-05 | 2019-06-26 | Dow Global Technologies LLC | Cellulose ether powders |
CN107667121A (zh) * | 2015-06-05 | 2018-02-06 | 陶氏环球技术有限责任公司 | 纤维素醚粉末 |
KR102519854B1 (ko) | 2016-10-07 | 2023-04-10 | 신에쓰 가가꾸 고교 가부시끼가이샤 | 히드록시알킬 알킬 셀룰로오스 및 그의 제조 방법, 및 고형 제제 |
KR102519850B1 (ko) * | 2016-10-07 | 2023-04-10 | 신에쓰 가가꾸 고교 가부시끼가이샤 | 히드록시알킬 알킬 셀룰로오스 및 그의 제조 방법, 및 고형 제제 |
CN113117131B (zh) * | 2019-12-31 | 2023-01-03 | 广州迈普再生医学科技股份有限公司 | 一种纳米纤维微球材料及其制备方法和应用 |
WO2022152760A1 (en) * | 2021-01-13 | 2022-07-21 | Nutrition & Biosciences Usa 1, Llc | Improved method for the preparation of colloidal microcrystalline cellulose |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB684561A (en) | 1949-09-22 | 1952-12-17 | British Celanese | Improvements in the manufacture of water-soluble cellulose ethers |
GB1514788A (en) | 1974-12-13 | 1978-06-21 | Hoechst Ag | Grinding method for cellulose |
US4076935A (en) * | 1974-12-13 | 1978-02-28 | Hoechst Aktiengesellschaft | Grinding method for cellulose |
DE3038001A1 (de) | 1980-10-08 | 1982-05-06 | Henkel KGaA, 4000 Düsseldorf | Verfahren zur herstellung von mikropulvern aus celluloseether oder cellulose |
US4734285A (en) | 1985-10-28 | 1988-03-29 | The Dow Chemical Company | Sustained release compositions |
US4820813A (en) * | 1986-05-01 | 1989-04-11 | The Dow Chemical Company | Grinding process for high viscosity cellulose ethers |
DE3839831A1 (de) | 1988-11-25 | 1990-05-31 | Hoechst Ag | Verfahren und vorrichtung zur produktschonenden mahlung und gleichzeitigen trocknung von feuchten celluloseethern |
GB2262527A (en) | 1992-07-02 | 1993-06-23 | Dow Deutschland Inc | Process for grinding cellulose compounds |
IT1266565B1 (it) * | 1993-07-22 | 1997-01-09 | Ct Lab Farm Srl | Composizioni farmaceutiche a rilascio controllato a base di uno o piu' sali farmaceuticamente accettabili dell'acido gamma-idrossi-butirrico. |
US5488104A (en) * | 1994-06-30 | 1996-01-30 | The Dow Chemical Company | Process for comminuting cellulose ethers |
EP0824107A3 (de) | 1996-08-12 | 1998-04-22 | Lenzing Aktiengesellschaft | Cellulosepartikel |
DE19641781A1 (de) * | 1996-10-10 | 1998-04-16 | Clariant Gmbh | Verfahren und Vorrichtung zum gleichzeitigen Mahlen und Trocknen eines feuchten Celluloseether enthaltenden Mahlgutes |
EP0954536B2 (de) | 1997-01-21 | 2009-01-07 | Dow Wolff Cellulosics GmbH | Verfahren zur herstellung von feinteiligen polysaccharidderivaten |
DE10009409A1 (de) | 2000-02-28 | 2001-08-30 | Wolff Walsrode Ag | Verfahren zur Herstellung von pulverförmigen wasserlöslichen Cellulosederivaten |
DE10009411A1 (de) | 2000-02-28 | 2001-08-30 | Wolff Walsrode Ag | Verfahren zur Herstellung pulverförmiger wasserlöslicher Cellulosederivate unter Einsatz eines Wasserdampf/Inertgas-Gemisch oder Wasserdampf/Luft-Gemisch als Transport und Wärmeträgergas |
DE102004020686B3 (de) * | 2004-04-28 | 2006-01-05 | Se Tylose Gmbh & Co. Kg | Verfahren und Vorrichtung zur Mahlung von Cellulose |
MX2008002164A (es) * | 2005-08-16 | 2008-04-22 | Dow Wolff Cellulosics Gmbh | Metodo para producir productos de eter de celulosa con mayor viscosidad y finura. |
US20070082035A1 (en) * | 2005-10-06 | 2007-04-12 | New York Blood Center, Inc. | Anti-infective hygiene products based on cellulose acetate phthalate |
US8519120B2 (en) * | 2006-08-08 | 2013-08-27 | Shin-Etsu Chemical Co., Ltd. | Methods for producing a low-substituted hydroxypropylcellulose powder |
DE102006057188A1 (de) * | 2006-12-05 | 2008-06-12 | Dow Wolff Cellulosics Gmbh | Celluloseether für Feststoffformulierungen |
EP2116264B1 (en) * | 2006-12-26 | 2017-09-27 | Shin Nippon Biomedical Laboratories, Ltd. | Preparation for transnasal application |
JP5612462B2 (ja) | 2007-04-13 | 2014-10-22 | ダウ グローバル テクノロジーズ エルエルシー | 剤形用の粒状物質 |
JP5258837B2 (ja) * | 2009-05-19 | 2013-08-07 | 信越化学工業株式会社 | 包餡食品用中種の製造方法とそれを含む食品 |
EP2598557B1 (en) * | 2010-07-28 | 2019-03-20 | Dow Global Technologies LLC | A process for dry-grinding a polysaccharide derivative |
MX343509B (es) * | 2011-04-06 | 2016-11-08 | Dow Global Technologies Llc | Proceso para producir derivados de celulosa de alta densidad aparente y buena fluidez. |
-
2012
- 2012-03-29 MX MX2013011588A patent/MX343509B/es active IP Right Grant
- 2012-03-29 US US14/009,432 patent/US9352330B2/en active Active
- 2012-03-29 CN CN201280015844.2A patent/CN103459430B/zh active Active
- 2012-03-29 KR KR1020187034609A patent/KR20180132952A/ko not_active Application Discontinuation
- 2012-03-29 JP JP2014503690A patent/JP5977331B2/ja active Active
- 2012-03-29 CN CN201610585804.1A patent/CN106188581B/zh active Active
- 2012-03-29 BR BR112013023380-0A patent/BR112013023380B1/pt active IP Right Grant
- 2012-03-29 EP EP12712851.0A patent/EP2694035A2/en active Pending
- 2012-03-29 KR KR1020137026351A patent/KR101960244B1/ko active IP Right Grant
- 2012-03-29 WO PCT/US2012/031111 patent/WO2012138532A2/en active Application Filing
-
2016
- 2016-05-23 US US15/140,786 patent/US20160256390A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2014510184A (ja) | 2014-04-24 |
KR20180132952A (ko) | 2018-12-12 |
BR112013023380A2 (pt) | 2017-04-25 |
KR20140027132A (ko) | 2014-03-06 |
CN103459430B (zh) | 2016-08-17 |
WO2012138532A3 (en) | 2013-02-28 |
CN103459430A (zh) | 2013-12-18 |
US9352330B2 (en) | 2016-05-31 |
CN106188581B (zh) | 2019-08-16 |
WO2012138532A2 (en) | 2012-10-11 |
US20140017319A1 (en) | 2014-01-16 |
MX2013011588A (es) | 2013-12-09 |
BR112013023380B1 (pt) | 2021-03-23 |
MX343509B (es) | 2016-11-08 |
KR101960244B1 (ko) | 2019-03-21 |
US20160256390A1 (en) | 2016-09-08 |
EP2694035A2 (en) | 2014-02-12 |
CN106188581A (zh) | 2016-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5977331B2 (ja) | 高い嵩密度と良好な流動性を有するセルロース誘導体の製造方法 | |
JP5731708B2 (ja) | 新規多糖類誘導体及び剤形 | |
JP5612462B2 (ja) | 剤形用の粒状物質 | |
JP6034365B2 (ja) | 高い嵩密度、良好な流動性及び改善された冷水分散性を有するセルロース誘導体の製造方法。 | |
JP5731723B2 (ja) | セルロースエーテルを含む溶融押出し組成物 | |
KR20150063464A (ko) | 높은 벌크 밀도, 우수한 유동성 및/또는 우수한 냉수 분산성 및 약한 용액 색을 갖는 셀룰로스 유도체의 제조 방법 | |
US9693960B2 (en) | Method of controlling the release of an active ingredient from a dosage form | |
JP2024528194A (ja) | コプロセス賦形剤顆粒を調製する方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131008 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140929 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150327 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160301 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160525 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160621 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160721 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5977331 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |